Psoriatic Arthritis Journal Articles

• Upadacitinib in Psoriatic Arthritis With Axial Involvement Is upadacitinib a safe and effective treatment option for psoriatic arthritis patients with axial involvement?
  Arthritis Research & Therapy, May 24, 2023
• Group-Based Cognitive Behavioral Therapy for Insomnia in RA Might individuals with rheumatoid arthritis suffering from insomnia realize benefits from a cognitive behavioral therapy intervention?
  Rheumatology, April 03, 2023
• Improved Outcomes in RA With Obesity After Weight Loss In this study, obese rheumatoid arthritis patients who successfully lost weight with a targeted diet and exercise intervention realized improved outcomes.
  Rheumatology, March 27, 2023
• Achilles Enthesitis and Outcomes in Ankylosing Spondylitis A new study shows that Achilles tendon enthesitis could have negative impacts over time in patients with ankylosing spondylitis.
  Arthritis Research & Therapy, March 24, 2023
• Risankizumab Induction Therapy for Patients With Crohn's Disease This study evaluated the effectiveness and safety of risankizumab induction therapy in a cohort of patients with Crohn's disease refractory to other biologic therapies.
  Alimentary Pharmacology & Therapeutics, February 16, 2023
• Selective TYK2 Inhibition in Chronic Plaque Psoriasis This articles focuses on oral deucravacitinib, a first-in-class selective tyrosine kinase 2 inhibitor for the treatment of moderate-to-severe chronic plaque psoriasis.
  Skin Therapy Letter, February 15, 2023
• AI and the Future of Radiographic Scoring in RA: A Viewpoint Radiographic scoring is used to assess disease progression and treatment efficacy in RA. Could AI have a role in improving and automating this process?
  Arthritis Research & Therapy, February 07, 2023
• SARS-CoV-2 Vaccination in Patients With Rheumatic Diseases SARS-CoV-2 vaccines have been shown to be safe and effective for the general population, but what do we know about the immune response in people with rheumatic diseases?
  Journal of Clinical Rheumatology, December 14, 2022
• New Onset/Exacerbations of Psoriasis After COVID-19 Vaccines Might COVID-19 vaccination be a triggering factor for psoriasis? This paper reveals that both new-onset psoriasis and psoriasis flares have been reported following COVID-19 vaccination.
  American Journal of Clinical Dermatology, November 11, 2022
• Nomogram for Predicting Overall Survival in Prostate Cancer Could this newly developed nomogram accurately predict the long-term survival of prostate cancer patients?
  Translational Andrology and Urology, November 08, 2022
• Testosterone Therapy in Prostate Cancer The use of testosterone therapy in hypogonadal men with coexisting prostate cancer has been controversial. What are the concerns, and does recent evidence support this strategy?
  Current Opinion in Urology, November 03, 2022
• Biomarkers of Systemic Treatment Response in Psoriasis This review provides a comprehensive catalog of candidate biomarkers of systemic treatment response in psoriasis.
  The British Journal of Dermatology, October 28, 2022
• Infliximab in Patients With Juvenile-Onset Spondyloarthritis Is infliximab an effective therapeutic option for patients with juvenile-onset spondyloarthritis who don't adequately respond to conventional treatment?
  Arthritis Research & Therapy, October 25, 2022
• Severe and Rare Infections Among Adults With Psoriasis This study found that as the severity of psoriasis increases, so does the risk of severe and rare infections.
  The British Journal of Dermatology, October 07, 2022
• An Update on JAK Inhibitors in Skin Disease This paper summarizes recent trials of JAK inhibitors tested in patients with moderate to severe atopic dermatitis, including topical RUX, oral abrocitinib, upadacitinib, and baricitinib.
  Cutis, September 28, 2022
• Enzalutamide Improves Survival in Metastatic Prostate Cancer A primary analysis of the ARCHES trial finds that the addition of enzalutamide to androgen deprivation therapy may help prolong the survival of metastatic hormone-sensitive prostate cancer patients.
  Journal of Clinical Oncology, September 27, 2022
• Critical Appraisal of Psoriasis Clinical Practice Guidelines This systemic review evaluating 33 recent psoriasis clinical practice guidelines found that most were unable to consistently demonstrate high quality across multiple appraisal tools.
  The British Journal of Dermatology, September 12, 2022
• Cabozantinib Combined With Atezolizumab for Advanced RCC This novel therapeutic combination shows encouraging results in patients with advanced renal cell carcinoma.
  Journal of Clinical Oncology, September 01, 2022
• TNF Inhibitors and CVD Risk in Axial Spondyloarthritis This study found no reduction in cardiovascular risk associated with the use of TNF inhibitors among patients with axial spondyloarthritis.
  Arthritis Research & Therapy, August 23, 2022
• Comparing Surgical Methods for Benign Prostatic Hyperplasia Various surgical options are available for the treatment of benign prostatic hyperplasia. How do these procedures compare in terms of efficacy and complication rates?
  Translational Andrology and Urology, August 19, 2022